2013
DOI: 10.3109/10428194.2013.823495
|View full text |Cite
|
Sign up to set email alerts
|

A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…As shown in our previous study, in platelet lysate (PL) supplemented cultures, MSC proliferates significantly better then when cultured with FCS [9]. Along with a higher proliferative index, PL could also alter MSC characteristics and its efficacy, leading to concerns about using fetal bovine serum and other non-human materials, evidence ensuring this is that MSC proliferates better using human derived materials, like platelet lisate (LP).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…As shown in our previous study, in platelet lysate (PL) supplemented cultures, MSC proliferates significantly better then when cultured with FCS [9]. Along with a higher proliferative index, PL could also alter MSC characteristics and its efficacy, leading to concerns about using fetal bovine serum and other non-human materials, evidence ensuring this is that MSC proliferates better using human derived materials, like platelet lisate (LP).…”
Section: Introductionmentioning
confidence: 99%
“…PL was produced in house. Briefly, platelets passed through freezing and thawing cycle, centrifuged 4 times at 3000 g for 30 min, sterilized through 0.22 µm filter, heparinized and stored in −20˚C freezer for up to 3 months [9].…”
Section: Isolation Expansion and Characterization Of Mesenchymal Strmentioning
confidence: 99%
See 1 more Smart Citation
“…Because of their immunosuppressory and engraftment-promoting properties, MSC have been used routinely in the clinical settings both to facilitate hematopoietic recovery and to treat steroid-resistant acute graft-versus-host disease [2]. Compared to other types of stem cells, MSC are considered as a useful cell source in tissue engineering owing to their high capacity for proliferation and differentiation [1, 3].…”
Section: Introductionmentioning
confidence: 99%
“…Following promising results of mesenchymal stem cells (MSC) in experimental studies and clinical trials, these cells have been recently presented as a candidate for cell-based therapy in solid organ transplantation and repair of damaged tissues such as bone, cartilage, muscle, ligament, tendon, and adipose [ 1 ]. Because of their immunosuppressory and engraftment-promoting properties, MSC have been used routinely in the clinical settings both to facilitate hematopoietic recovery and to treat steroid-resistant acute graft-versus-host disease [ 2 ]. Compared to other types of stem cells, MSC are considered as a useful cell source in tissue engineering owing to their high capacity for proliferation and differentiation [ 1 , 3 ].…”
Section: Introductionmentioning
confidence: 99%